Correlation Between Corvus Pharmaceuticals and Teva Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Teva Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Teva Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Teva Pharma Industries, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Teva Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Teva Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Teva Pharma.

Diversification Opportunities for Corvus Pharmaceuticals and Teva Pharma

CorvusTevaDiversified AwayCorvusTevaDiversified Away100%
-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Corvus and Teva is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Teva Pharma Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharma Industries and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Teva Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharma Industries has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Teva Pharma go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Teva Pharma

Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.87 times more return on investment than Teva Pharma. However, Corvus Pharmaceuticals is 1.14 times less risky than Teva Pharma. It trades about -0.39 of its potential returns per unit of risk. Teva Pharma Industries is currently generating about -0.36 per unit of risk. If you would invest  507.00  in Corvus Pharmaceuticals on November 27, 2024 and sell it today you would lose (113.00) from holding Corvus Pharmaceuticals or give up 22.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Teva Pharma Industries

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -40-20020
JavaScript chart by amCharts 3.21.15CRVS TEVA
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Corvus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb456789
Teva Pharma Industries 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharma Industries are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Teva Pharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb16171819202122

Corvus Pharmaceuticals and Teva Pharma Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-10.41-7.8-5.18-2.570.02.284.566.849.13 0.0100.0120.0140.0160.0180.0200.0220.024
JavaScript chart by amCharts 3.21.15CRVS TEVA
       Returns  

Pair Trading with Corvus Pharmaceuticals and Teva Pharma

The main advantage of trading using opposite Corvus Pharmaceuticals and Teva Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Teva Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharma will offset losses from the drop in Teva Pharma's long position.
The idea behind Corvus Pharmaceuticals and Teva Pharma Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated